The White House Council of Economic Advisers (CEA) has released a reportestimating the likely effects of a nationwide ban on several hospital contracting practices that, in the Administration’s view, serves to shield dominant systems from price competition. Specifically, the report focuses on anti-steering clauses, which prohibit insurers from directing patients toward lower-cost providers; anti-tiering clauses, a form of anti-steering that bars insurers from placing a dominant system in a less favorable benefit tier; and all-or-nothing contracting, which requires insurers to accept every hospital and affiliated physician in a system, or none at all. The report notes that these provisions can make it harder for insurers to build lower-cost plans and can help powerful systems maintain prices above competitive levels.
These concepts align closely with the federal government’s recent lawsuit against two large health systems. In February 2026, the US Department of Justice (DOJ) and the State of Ohio jointly filed an antitrust lawsuit against an Ohio health system, and in March 2026, DOJ filed a similar lawsuit against a New York health system, alleging that both defendants' terms in agreements with insurers obstruct lower-cost plan designs and hinder competition. (The DOJ’s lawsuit against the New York system followed class action claims brought by union-affiliated health plans against the system.) The Ohio system has since entered a proposed consent judgment, while the New York system case remains pending.
If approved, the proposed consent judgment would void all existing contract provisions of the Ohio system that prohibit, deter, prevent or penalize steering, tiered networks and price transparency, and bar the system from seeking or obtaining contract terms that penalize or restrict payors from designing or offering narrow network, tiered, reference-based pricing or site-of-service steered plans, prohibit retaliation against payors that offer such plans, engage in steering or communicate price or cost transparency information to their members, and subject the system to a court-appointed monitor for five years of monitoring and quarterly reporting obligations funded at the system's expense. The judgment itself runs for 10 years, with the possibility of early termination after five years at the DOJ's discretion.
Hospitals and health systems should be aware that, taken together, the CEA report and the DOJ actions point to meaningful federal enforcement and policy direction and should be treated as a serious signal of how the government is likely to view these provisions going forward.
Key findings and projected economic effects
The CEA report estimates that banning these provisions would reduce hospital and affiliated-physician prices in directly affected markets by approximately 18 percent, with a plausible range of 11 to 26 percent. It also estimates a 6.5 percent reduction in employer-sponsored insurance premiums in those markets, equal to roughly US$1,800 per family and US$600 per individual each year in 2025 dollars. Because the report estimates that 24 percent of employer-sponsored insurance enrollees are in markets where these clauses are binding and consequential, the projected national savings would be about US$45 billion per year.
The report credits the reductions primarily to four interconnected factors: improved bargaining power for insurers, an increase in patients seeking lower-cost providers, stronger competitive alternatives as rival systems gain market share over time and a distinct fourth mechanism: cross-market spillover. All-or-nothing and anti-steering clauses allow a dominant system in one market to raise prices in separate geographic markets as well. Eliminating these clauses would disconnect one system's market power from the prices negotiated in other markets.
The issue also extends beyond facility rates. The report treats affiliated physician contracting as part of the same economic picture, and separate industry data show that health system employment of physicians is now widespread and often associated with higher negotiated commercial prices than independent practice settings.
The report further indicates that the effects will vary by market structure. In general, the largest effects are expected where a system is important enough that insurers cannot realistically exclude it from a network, while the expected effects are more limited where competitive dynamics differ. The broader point for management teams is that these issues are most acute where market position gives a system substantial negotiating leverage.
Rural hospitals and the cross-subsidy argument
The report casts doubt on the claim that these contracting practices are essential to supporting rural and safety-net facilities. It argues that multi-market systems may use their bargaining power in one area to maintain higher prices in another, including rural communities. Similar theories have emerged in antitrust lawsuits filed by local governments, specifically consolidated cases against two major health systems operating in western Norton Carolina, filed by the City of Brevard, City of Asheville, Buncombe County and Madison County, which were settled in August 2025.
A 2021 settlement with a large California-based health system is likely to remain part of that discussion. Under the settlement, the system agreed to halt all-or-nothing contracting and anti-steering practices system wide. Recent history indicates that its rural operations continued after the settlement. Those developments do not resolve the policy debate, but they give policymakers a response to the claim that removing these clauses necessarily undermines rural operations.
What your organization can do now
The following areas merit immediate attention from leadership teams:
- Review payor agreements through both strategic and legal lenses, with particular focus on provisions that limit steering, tiering, narrow-network design, site-of-service steering or price transparency.
- Assess how central those provisions are to the system’s pricing, volume and network strategy, including whether the organization is relying on them to protect market position, preserve contracting leverage or support performance across affiliated hospitals and physician groups.
- Prepare for challenge, whether from a regulator or a major payor, by deciding in advance how the organization would respond if those provisions became a point of negotiation, investigation or enforcement scrutiny.
The CEA report is an economic policy document rather than a legal mandate. But, when paired with the Ohio-based system's proposed consent judgment and the pending New York litigation, it should be read as a serious warning signal for hospitals and health systems that use, or may be perceived as relying on, these types of contract restrictions.